Marroni, M <br/><br/>
Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial.  [electronic resource] 

 -  Annals of internal medicine  Sep 1994 
 - 423-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-4819 
<br/><br/><label>Standard No.: </label>10.7326/0003-4819-121-6-199409150-00005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acquired Immunodeficiency Syndrome--complications<br/>Adult<br/>Bleeding Time<br/>Double-Blind Method<br/>Female<br/>HIV-1<br/>Humans<br/>Interferon-alpha--adverse effects<br/>Male<br/>Platelet Count<br/>Prospective Studies<br/>Thrombocytopenia--blood<br/>Zidovudine--therapeutic use